- Building a workforce engine for biomanufacturingOhio’s $30M training initiative aims to scale talent pipelines and power life sciences growth statewide.Fierce Biotech · 13d ago↗ source
- Tris Pharma's CRL for narcolepsy drug; Agenus abandons Phase 3 CRC trialPlus, news about Insilico, Ipsen, Q32 Bio, GSK’s Jemperli, Drug Farm and Padcev. ❌ FDA rejects Tris Pharma’s narcolepsy drug: Its rejection letter said that “additional information will be necess…Endpoints · 13d ago↗ source
- STAT+: All eyes on data on Biogen’s tau therapyThe year of daraxonrasib, a wearable for a myeloma drug, and more biotech news from The ReadoutSTAT · 13d ago↗ source